NCT01759342

Brief Summary

This protocol was designed to assess if when subjects with CF are admitted to the hospital for a pulmonary exacerbation if a comprehensive exercise program (moderate to high intensity aerobic, resistance, flexibility and balance exercises) was superior to our "usual care intervention (30 min/day of self selected mode and intensity of exercise) in improving aerobic capacity, muscle strength/power, flexibility and balance.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Apr 2008

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 1, 2008

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2008

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

October 1, 2008

Completed
4.2 years until next milestone

First Submitted

Initial submission to the registry

December 21, 2012

Completed
13 days until next milestone

First Posted

Study publicly available on registry

January 3, 2013

Completed
Last Updated

June 30, 2015

Status Verified

December 1, 2012

Enrollment Period

6 months

First QC Date

December 21, 2012

Last Update Submit

June 27, 2015

Conditions

Keywords

Cystic fibrosis; pulmonary exacerbation, exercise

Outcome Measures

Primary Outcomes (1)

  • Aerobic capacity following intervention of a comprehensive excercise training program

    Participants will be followed for the duration of hospital stay, average number of days 10 (range 4 - 20 days)

Secondary Outcomes (3)

  • Muscle strength and power following intervention of a comprehensive excercise training program

    Participants will be followed for the duration of hospital stay, average number of days 10 (range 4 - 20 days)

  • Posture/flexibility following intervention of a comprehensive excercise training program

    Participants will be followed for the duration of hospital stay, average number of days 10 (range 4 - 20 days)

  • Balance following intervention of a comprehensive excercise training program

    Participants will be followed for the duration of hospital stay, average number of days 10 (range 4 - 20 days)

Study Arms (2)

Comprehensive exercise program

EXPERIMENTAL

Moderate to high intensity aerobic, resistance, flexibility, posture and balance exercise program

Behavioral: Aerobic exerciseBehavioral: Resistance exerciseBehavioral: Flexibility and postural exerciseBehavioral: Balance exercise

Usual care exercise

ACTIVE COMPARATOR

30 minutes/day of self selected mode and intensity of aerobic exercise

Behavioral: Aerobic exercise

Interventions

Comprehensive exercise programUsual care exercise
Comprehensive exercise program
Comprehensive exercise program
Comprehensive exercise program

Eligibility Criteria

Age6 Years - 21 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64)

You may qualify if:

  • age 6 to 21 years
  • admission for an acute Cystic fibrosis (CF) exacerbation
  • forced expiratory volume in 1 s (FEV1) of \< 60% of predicted at admission

You may not qualify if:

  • medically unstable as deemed by the attending physician
  • had completed both arms of the present study

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University of Alabama at Birmimgham

Birmingham, Alabama, 35233, United States

Location

MeSH Terms

Conditions

Cystic FibrosisMotor Activity

Interventions

ExerciseResistance TrainingPliability

Condition Hierarchy (Ancestors)

Pancreatic DiseasesDigestive System DiseasesLung DiseasesRespiratory Tract DiseasesGenetic Diseases, InbornCongenital, Hereditary, and Neonatal Diseases and AbnormalitiesInfant, Newborn, DiseasesBehavior

Intervention Hierarchy (Ancestors)

Motor ActivityMovementMusculoskeletal Physiological PhenomenaMusculoskeletal and Neural Physiological PhenomenaExercise TherapyRehabilitationAftercareContinuity of Patient CarePatient CareTherapeuticsPhysical Therapy ModalitiesPhysical Conditioning, HumanMechanical PhenomenaPhysical Phenomena

Study Officials

  • John D Lowman, PT, PhD

    University of Alabama at Birmingham

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
CROSSOVER
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 21, 2012

First Posted

January 3, 2013

Study Start

April 1, 2008

Primary Completion

October 1, 2008

Study Completion

October 1, 2008

Last Updated

June 30, 2015

Record last verified: 2012-12

Locations